
Please try another search
Welichem Biotech Inc., a development stage biotechnology company, engages in the discovery and development of therapeutic drugs for autoimmune diseases and cancers. Its lead drug candidate, WBI-2100, is in the pre-clinical stage of development to treat various cancerous tumors. The company is developing product candidates through its Symbiochem technology platform. Welichem Biotech Inc. is based in Burnaby, Canada. As of June 19, 2014, Welichem Biotech Inc. operates as a subsidiary of LJ Resources Co., Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review